Jiangsu Hengrui Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is IODIXANOL USP, with a corresponding US DMF Number 31200.
Remarkably, this DMF maintains an Active status since its submission on January 11, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 14, 2017, and payment made on December 30, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II